FDA NDC Directory · JSON-LD · Markdown

ZELAPAR

NDC 0187-0453 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameSELEGILINE HYDROCHLORIDE
Labeler / ManufacturerBausch Health US, LLC
Marketing categoryNew Drug Application (innovator) · App NDA021479
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsSELEGILINE HYDROCHLORIDE (1.25 mg/1)
Marketing started20060614
Package count1

External sources

Source: openFDA. Public-domain (CC0).